The anticonvulsant effect of geraniol and inclusion complex geraniol: beta-cyclodextrin / El efecto anticonvulsivo de geraniol y la inclusión de geraniol complejo: beta-ciclodextrina

Geraniol (GR) is an acyclic monoterpene alcohol present in essential oils of aromatic plant species used in Brazilian folk medicine for the treatment of epilepsy. The present study was designed to evaluate the anticonvulsant effect of GR and of the inclusion complex geraniol:beta-cyclodextrin (GR:beta-CD). Mice were treated with GR or with GR:beta-CD (50, 100 and 200 mg/kg) 30 min before pentylenetetrazole (PTZ) or strychnine (STN). GR at 200 mg/kg and GR:beta-CD at the doses of 100 and 200 mg/kg significantly increased the latency for the first PTZ-induced convulsion and reduced the percentage of animals that convulsed. The pretreatment of flumazenil did not revert the anticonvulsant effect of GR in the PTZ-induced convulsion model. In the STN-induced convulsion model, the effects of GR were investigated and no difference was found against control. The results demonstrated an anticonvulsant activity of GR in the PTZ-model, which was potentialized by the complexation with beta-CD...

Geraniol (GR) es un alcohol monoterpeno acíclico presentes en los aceites esenciales de las especies de plantas aromáticas utilizadas en la medicina popular brasileña para el tratamiento de la epilepsia. El presente estudio fue diseñado para evaluar el efecto anticonvulsivo del GR y de la inclusión de geraniol complejo: beta-ciclodextrina (GR:beta-CD). Los ratones fueron tratados con GR o con GR:beta- CD (50, 100 y 200 mg/kg) 30 minutos antes de pentylenotetrazole (PTZ) o strichinine (STN). GR a 200 mg/kg y GR:beta-CD en las dosis de 100 y 200 mg/kg aumentó significativamente la latencia para la primera convulsión inducida PTZ-y redujo la porcentaje de animales que convulsionó. El tratamiento previo de flumazenil no revirtió el efecto anticonvulsivo de GR en el modelo de convulsión inducida con PTZ. En el modelo de convulsión inducida com STN, los efectos de GR fueron investigados y no se encontró ninguna diferencia contra el control. Los resultados demostraron una actividad anticonvulsiva de geraniol en el modelo de PTZ, que fue potenciada por la formación de complejos con beta-CD...

Therapeutic Potential of Myrrh and Ivermectin against Experimental Trichinella spiralis Infection in Mice

Trichinosis is a parasitic zoonosis caused by the nematode Trichinella spiralis. Anthelmintics are used to eliminate intestinal adults as well as tissue-migrating and encysted larvae. This study aimed to investigate the effects of ivermectin and myrrh obtained from the aloe-gum resin of Commiphora molmol on experimental trichinosis. Ninety albino mice were orally infected with 300 T. spiralis larvae. Drugs were tested against adult worms at day 0 and day 5 and against encysted larvae on day 15 and day 35 post-infection (PI). Mature worms and encysted larvae were counted in addition to histopathological examination of muscle specimens. Serum aspartate aminotransferase (AST), alanine aminotransferase (ALT), total protein, albumin, globulin, urea, and creatinine values were estimated. Significant reductions in mean worm numbers were detected in ivermectin treated mice at day 0 and day 5 PI achieving efficacies of 98.5% and 80.0%, while efficacies of myrrh in treated mice were 80.7% and 51.5%, respectively. At days 15 and 35 post-infection, ivermectin induced significant reduction in encysted larval counts achieving efficacies of 76.5% and 54.0%, respectively, while myrrh efficacies were 76.6% and 35.0%, respectively. AST, ALT, urea, and creatinine levels were reduced, while total proteins were increased in response to both treatments compared to their values in the infected non-treated mice. Ivermectin use for controlling T. spiralis could be continued. Myrrh was effective and could be a promising drug against the Egyptian strains of T. spiralis with results nearly comparable to ivermectin.

Transdermal permeation of trimetazidine from nerodilol-based HPMC gel drug reservoir system across rat epidermis

To study the in vitro transdermal permeation of trimetazidine from hydroxypropylmethyl cellulose [HPMC] gel drug reservoir system using nerodilol as a penetration enhancer. An HPMC gel containing selected concentrations of nerodilol [0, 2, 4 or 5% w/v] and 2.5% w/v of trimetazidine was prepared, and subjected to in vitro permeation studies across rat epidermis. The amount of trimetazidine permeated at different time intervals [1, 2, 4, 8, 12, 18 and 24 h] was estimated, and the data were analyzed to calculate various permeation parameters. There was an increase in the amount of trimetazidine [8,719.7 +/- 153.3 micro g/cm[2]] permeated across the rat epidermis up to 24 h [Q[24]] with an increase in nerodilol concentration [5% w/v] in HPMC gel drug reservoir. However, no significant difference [p > 0.05] was observed in the amount of drug permeated [Q[24]] with 5% w/v of nerodilol when compared to that obtained with 4% w/v of nerodilol [8,484.5 +/- 165.8 micro g/ cm[2]]. Nerodilol, at a concentration of 4% w/v enhanced the flux of trimetazidine across rat epidermis by about 1.96 times when compared to control. The HPMC gel drug reservoir containing 4% w/v of nerodilol showed optimal transdermal permeation of trimetazidine

[Spasmolytic effect of zataria multiflora boiss leaf extract on rat uterus]

Zataria multiflora Boiss is used in traditional medicine to treat gastrointestinal disorders and menrrhalgia. The inhibitory effect of this herb on rat ileuni contractions has also been reported. The aim of this study was to investigate the effect of Zataria multiflora Boiss hydroalcoholic leaf extract [ZHLE] on isolated rat uterus in the presence of some known uterus stimulants. Pieces of virgin adult rat uterus were mounted in an organ bath containing Tyrode or De Jalon solutions. Uterus contractions were induced by KCI, oxytocin and BaC1[2] in presence and absence of ZHLE. Animals in oxytocin studies received an injection of oestradiol valerate [5mg/kg, s.c.] 24 h prior experiment. ZHLE [0.125, 0.25, 0.5, 1 and 2 mg/ml] relaxed the uterus precontracted by KC1 [60mM] in a dose-dependent manner [p<0.0001] and at 2mg/mi attenuated the BaC1[2] [4mM]-induced uterus contraction significantly [p<0.001]. The inhibitory effect of ZLHE on KC1-induced uterus contraction was unaffected by propranolol [1 micro M]. in normal IDe Jalon solution, ZHLE [0.125, 0.25, 0.5, and 1 mg/ml] reduced the oxytocin [10mU/ml]-induced contraction dose-dependently [p<0.0001] but in Ca[2+]-free Dc Jalon solution, the stimulatory effect of oxytocin was weaker and also the inhibitory effect of ZHLF was more consistent. In presence of atropine [0.5jiM], acetylcholine [0.5jiM] failed to induce contraction but KC1 [30mM]-evoked contraction and extract diminished the contractile response of KC1. The spasmolytic effect of extract [2mg/ml] on KC1-induced contraction was unaffected by naloxone [1 micro M]. From the obtained results it may be concluded that, the ZHLE may induce its inhibitory effect through blockage of the voltage dependent calcium channels and releasing calcium from intracellular stores in rat uterus smooth muscle. The ineffectiveness of propranolol and naloxone on ZLHE inhibitory effect indicates that adrenergic and opoids agonist substance[s] did not exist in the extract. it seems that there was no anticholinergic substance[s] in the extract. The results support the usage of this plant in traditional medicine

The effect of indigenous Neem Azadirachta indica [correction of (Adirachta indica)] mouth wash on Streptococcus mutans and lactobacilli growth.

Neem is one of the most widely researched tropical tree, with almost all it's parts being put for a variety of uses. In the present study, the antibacterial effect of Neem mouthwash against salivary levels of streptococcus mutans and lactobacillus has been tested over a period of 2 months. Also it's effect in reversing incipient carious lesions was assessed. While streptococcus mutans was inhibited by Neem mouthwashes, with or without alcohol as well as chlorhexidine, lactobacillus growth was inhibited by chlorhexidine alone. The initial data appears to prove it's effect in inhibiting S. mutans and reversing incipient carious lesions, longer term clinical trials are essential.

Effect of beta-myrcene on pentobarbital sleeping time

Evidence that beta-myrcene (MYR) interferes with the metabolic activation of premutagens has been provided by in vitro studies. In order to determine whether MYR also interferes with the in vivo metabolism of xenobiotics, thereby modifying pharmacological responses to drugs, we investigated the effects of this monoterpene on pentobarbital (PT) sleeping time in rats. Two experiments were carried out. In the first, a single dose of MYR (0.25, 0.5 or 1.0 g/kg po) was given 1 h before PT (40 mg/kg ip). No effect was observed with the two lowest doses, but the highest MYR dose given 1 h before PT increased the PT-induced sleeping time (131 +/- 15 min vs 64 +/- 15 min for controls, mean +/- SD). In the second experiment, male rats were treated with MYR (1.0 g/kg po once a day) for 14 days and injected with PT (40 mg/kg ip) 24 h after the last dose of MYR. Repeated treatment with MYR markedly reduced PT sleeping time compared to the vehicle-treated control group (21 +/- 13 min vs 35 +/- 19 min for controls, mean +/- SD). These results indicate that MYR interferes with the in vivo barbiturate metabolism and support the view that MYR induces the phenobarbital-inducible cytochrome P-450 (P-450 2B subfamily) enzymes in the rat